Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1999 | Direct solid-phase synthesis of octreotide conjugates: precursors for use as tumor-targeted radiopharmaceuticals | Hsieh, HP; Wu, YT; Chen, ST; Wang, KT | Bioorganic & Medicinal Chemistry 7, 1797-1803 | | | |
2006 | Discovery of different types of inhibition between the human and thermotoga maritima alpha-fucosidases by fuconojirimycin-based derivatives | Ho, CW; Lin, YN; Chang, CF; Li, ST; Wu, YT; Wu, CY; Chang, CF; Liu, SW; Li, YK; Lin, CH | Biochemistry 45, 5695-702 | | | |
2006 | Discovery of Different Types of Inhibition between the Human and Thermotoga maritime alpha-Fucosidases by Fuconojirimycin-based Derivatives. | Ho, CW; Lin, YN; Chang, CF; Li, ST; Wu, YT; Wu, CY; Chang, CF; Liu, SW; Li, YK; Lin, CH | Biochemistry 45, 5695-5702 | | | |
2005 | Discovery of Potent Anilide Inhibitors against the Severe Acute Respiratory Syndrome 3CL Protease | Shie, JJ; Fang, JM; Kuo, CJ; Kuo, TH; Liang, PH ; Huang, HJ; Yang, WB ; Lin, CH ; Chen, JL; Wu, YT; Wong, CH | Journal of Medicinal Chemistry 48(13), 4469-4473 | | | |
2020 | Disrupting the Conserved Salt Bridge in the Trimerization of Influenza A Nucleoprotein | Woodring, JL; Lu, SH; Krasnova, L; Wang, SC; Chen, JB; Chou, CC; Huang, YC; Cheng, TR ; Wu, YT; Chen, YH; Fang, JM; Tsai, MD; Wong, CH | Journal of medicinal chemistry 63(1), 205-215 | | | |
2011 | E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors | Shen, YF; Chen, YH; Chu, SY; Lin, MI; Hsu, HT; Wu, PY; Wu, CJ; Liu, HW; Lin, FY; Lin, G; Hsu, PH; Yang, AS; Cheng, YS; Wu, YT; Wong, CH; Tsai, MD | Proceedings of the National Academy of Sciences of the United States of America 108, 16515-16520 | | | |
2012 | Effects of Extreme Precipitation to the Distribution of Infectious Diseases in Taiwan, 1994–2008 | Chen, MJ; Lin, CY; Wu, YT; Wu, PC; Lung, SC; Su, HJ | PLoS One 7(6), e34651 | | | |
2018 | Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome. | Wu, YT; Hsu, YH; Huang, CY; Ho, MC; Cheng, YC; Wen, CH; Ko, HW; Lu, HE; Chen, YC; Tsai, CL; Hsu, YC; Wei, YH; Hsieh, PC | Stem Cell Research 27, 10-14 | | | |
2017 | Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene | Hsu, YH; Wu, YT; Huang, CY; Ho, MC; Cheng, YC; Syu, SH; Lu, HE; Chen, YC; Tsai, CL; Lin, HC; Wei, YH; Hsu, YC; Hsieh, PC | Stem Cell Research 25, 245-249 | | | |
2006 | Grid-enabled High-throughput in silico Screening against Influenza A Neuraminidase | Lee, HC; Salzemann, J; Jacq, N; Chen, HY; Ho, LY; Merelli, I; Milanesi, L; Breton, V; Lin, SC; Wu, YT | IEEE TRANSACTIONS ON NANOBIOSCIENCE 5(4), 288-295 | | | |
2009 | HA-pseudotyped retroviral vector for influenza antagonist screening. | Wang, SY; Su, CY; Lin, M; Huang, SY; Huang, WI; Wang, CC; Wu, YT; Cheng, TJ; Yu, HM; Ren, CT; Wu, CY; Wong, CH; Cheng, YS | Journal of Biomolecular Screening 14(3), 294-302 | | | |
2009 | HA-pseudotyped retroviral vectors for influenza antagonist screening | Wang, SY; Su, CY; Lin, M; Huang, SY; Huang, WI; Wang, CC; Wu, YT; Cheng, TJ; Yu, HM; Ren, CT; Wu, CY; Wong, CH; Cheng, YS | JOURNAL OF BIOMOLECULAR SCREENING 14(3), 294-302 | | | |
2010 | High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. | Su, CY; Cheng, TJ; Lin, MI; Wang, SY; Huang, WI; Lin-Chu, SY; Chen, YH; Wu, CY; Lai, MM; Cheng, WC; Wu, YT; Tsai, MD; Cheng, YS; Wong, CH | Proceedings of the National Academy of Sciences of the United States of America 107(45), 19151-19156 | | | |
2005 | Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters. | Shie, JJ; Fang, JM; Kuo, TH; Kuo, CJ; Liang, PH ; Huang, HJ; Wu, YT; Jan, JT; Cheng, YS; Wong, CH | BIOORGANIC & MEDICINAL CHEMISTRY 13, 5240-5252 | | | |
2009 | Innovative in silico approaches to address avian flu using grid technology | Breton, V; da Costa, AL; de Vlieger, P; Kim, YM; Maigne, L; Reuillon, R; Sarramia, D; Truong, NH; Nguyen, HQ; Kim, D; Wu, YT | Infect Disord Drug Targets 9, 358-65 | | | |
2006 | Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis | Liang, PH; Cheng, WC; Lee, YL; Yu, HP; Wu, YT; Lin, YL; Wong, CH | Chembiochem. 7, 165-173 | | | |
2001 | Proteomic analysis of proteins in PC12 cells before and after treatment with nerve growth factor: increased levels of a 43-kDa chromogranin B-derived fragment during neuronal differentiation | Huang, CM; Shui, HA; Wu, YT; Chu, PW; Lin, KG; Kao, LS; Chen, ST | Molecular Brain Research 92, 181-192 | | | |
2011 | Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury. | Wang, CY; Chen, JK; Wu, YT; Tsai, MJ; Shyue, SK; Yang, CS; Tzeng, SF | Journal of biomedical science 18, 13 | | | |
2006 | Stable benzotriazole esters as mechanism-based inhibitors of the severe acute respiratory syndrome 3CL protease | Wu, CY; King, KY; Kuo, CJ; Fang, JM; Wu, YT; Ho, MY; Liao, CL; Shie, JJ; Liang, PH ; Wong, CH | Chem Biol 13, 261-268 | | | |
2016 | Structural Investigation of Park's Nucleotide on Bacterial Translocase MraY: Discovery of Unexpected MraY Inhibitors. | Chen, KT; Chen, PT; Lin, CK; Huang, LY; Hu, CM; Chang, YF; Hsu, HT; Cheng, TJ; Wu, YT; Cheng, WC | Scientific reports 6, 31579 | | | |